Login / Signup

Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Iris DekkerA J C EijlersVeronica PopescuL J BalkHugo VrenkenM P WattjesB M J UitdehaagJ KillesteinJ J G GeurtsFrederik BarkhofMenno Michiel Schoonheim
Published in: European journal of neurology (2019)
Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures.
Keyphrases
  • multiple sclerosis
  • white matter
  • high resolution
  • mass spectrometry
  • photodynamic therapy